Gal Maier

1.9k citations
5 papers · 714 · 1 hit paper · h-index 3

Impact in

Papers in

Gal Maier

5 papers receiving 712 citations

Gal Maier's Hit Papers

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer 2009 · 449 citations
4490+5+11Years since publication100200300400

Peers

Gal Maier
Comparison fields: 5 of 42
  • Pulmonary and Respiratory Medicine 621
  • Cancer Research 172
  • Endocrinology, Diabetes and Metabolism 147
  • Radiology, Nuclear Medicine and Imaging 140
  • Hematology 48
Replace Emilda Thompson with:
Emilda Thompson United Kingdom
Robert J. van Soest Netherlands
Ellen S. de Morrée Netherlands
Shivang Doshi United States
Reetta Riikonen Finland
R. Nevin Murray Canada
Avery Spitz United States
Dan Brigham
Gang Shao
Oliver Sartor United States
Gal Maier relative to Emilda Thompson United Kingdom Emilda Thompson's profile →
Citations per field
00.5×1.6×
Emilda Thompson · 1×
Citations per year

Countries citing papers authored by Gal Maier

Since Specialization
Citations

This map shows the geographic impact of Gal Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Maier more than expected).

Fields of papers citing papers by Gal Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Maier. The network helps show where Gal Maier may publish in the future.

Co-authors

The 25 scholars most cited alongside Gal Maier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gal Maier Line = papers co-authored together Gal Maier links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
Hit paper breakdown →
2009449
2 2012194
3 201369
4
Abiraterone acetate: the novel application of a CYP450c17 inhibitor to the treatment of both prostate and breast cancer
20091
5 20121

About Gal Maier

Gal Maier is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Genetics and Infectious Diseases, having authored 5 papers that have together received 714 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Cancer, Lipids, and Metabolism (2 papers), Estrogen and related hormone effects (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (621 citations), Cancer Research (172 citations), Endocrinology, Diabetes and Metabolism (147 citations), Radiology, Nuclear Medicine and Imaging (140 citations) and Hematology (48 citations). Gal Maier has collaborated with scholars based in United Kingdom. Frequent co-authors include Johann S. de Bono, David Olmos, Gerhardt Attard, Emilda Thompson, Nikhil Babu Oommen, Christina Messiou, L. Rhoda Molife, Christopher Parker, Alison Reid and Mitch Dowsett. Their work appears in journals such as Journal of Clinical Oncology, European Urology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact